| Original language | English (US) |
|---|---|
| Pages (from-to) | 1398-1403 |
| Number of pages | 6 |
| Journal | American journal of hematology |
| Volume | 97 |
| Issue number | 11 |
| DOIs |
|
| State | Published - Nov 2022 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: American journal of hematology, Vol. 97, No. 11, 11.2022, p. 1398-1403.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - A roadmap for clinical trial design in marginal zone lymphoma
AU - Alderuccio, Juan Pablo
AU - Habermann, Thomas
AU - Kuker, Russ
AU - Moskowitz, Craig H.
AU - Zelenetz, Andrew D.
AU - Lossos, Izidore S.
N1 - Funding Information: Jaime Erin Follicular Lymphoma Research Consortium; the Dwoskin and Anthony Rizzo Families Foundations; the Intramural Funding Program from the University of Miami SCCC; National Cancer Institute, Grant/Award Numbers: U01 CA195568, 1R01CA233945; Peykoff Initiative from the Lymphoma Research Foundation Funding information Funding Information: J.P.A. consultant for and research funding for ADC Therapeutics. An immediate family member has served on the advisory boards of Puma Biotechnology, Inovio Pharmaceuticals, Agios Pharmaceuticals, Forma Therapeutics, and Foundation Medicine. A. D. Z. reports consulting fees from Adaptive Biotechnologies, Abbvie, Amgen, AstraZeneca, Beigene, Bristol Myers Squibb, Celgene, Genentech/Roche, Gilead, MEI Pharma, MorphoSys, NCCN, Novartis, and Verastem, data safety monitoring committee membership for BMS, Celgene, and Juno, data safety monitoring committee membership chair for Beigene, and research funding from MEI Pharma, Gilead, Beigene, and Roche. I.S.L. has served on the advisory boards of Adaptive Biotechnologies. Funding Information: J.P.A. is supported by Peykoff Initiative from the Lymphoma Research Foundation and the Dwoskin Family Foundation. I.S.L. is supported by grant 1R01CA233945 and U01 CA195568 from the National Cancer Institute, the Intramural Funding Program from the University of Miami SCCC, by the Dwoskin and Anthony Rizzo Families Foundations and Jaime Erin Follicular Lymphoma Research Consortium.
PY - 2022/11
Y1 - 2022/11
UR - http://www.scopus.com/inward/record.url?scp=85137790900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137790900&partnerID=8YFLogxK
U2 - 10.1002/ajh.26706
DO - 10.1002/ajh.26706
M3 - Comment/debate
C2 - 36030403
AN - SCOPUS:85137790900
SN - 0361-8609
VL - 97
SP - 1398
EP - 1403
JO - American journal of hematology
JF - American journal of hematology
IS - 11
ER -